PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Peuskens, Joseph
ED  - Falkai, Peter
TI  - Quetiapine for the Treatment of Schizophrenia—Selected Posters
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 14--14
VI  - 8
IP  - 3
4099  - http://mdc.sagepub.com/content/8/3/14.1.short
4100  - http://mdc.sagepub.com/content/8/3/14.1.full
AB  - Schizophrenia accounts for a significant portion of the global burden of neuropsychiatric disorders. It is often refractory to treatment and relapse due to poor adherence is also common. In addition, treatments for schizophrenia are frequently associated with side effects that can cause serious medical problems, such as cardiovascular disease. Quetiapine is approved for the treatment of schizophrenia and impacts a broad range of symptoms that affect quality of life.